Multi-country Survey on Violence Against Women Among Women
Launched by CHULALONGKORN UNIVERSITY · Apr 2, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is a study that aims to understand violence against women, specifically focusing on women aged 15 to 49 in countries across Asia and Oceania. The researchers want to learn how common violence against women is, what women know and think about it, and what kind of support services these women might need. This information is important to help improve support for women who may be experiencing violence in their lives.
To participate in this study, women must be aged between 15 and 49 years and have had a partner, which can include current or former husbands, cohabiting partners, or non-cohabiting male partners. The study is not yet recruiting participants, but once it starts, eligible women can expect to be asked questions about their experiences and views related to violence against women. This will help researchers gather valuable insights to create better resources and support for women in similar situations.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • ever-partnered women
- • aged 15-49 years
- • The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.
- Exclusion Criteria:
- • declined to participate
- • dropped out midway
About Chulalongkorn University
Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Unnop Jaisamrarn, MD,MHS
Principal Investigator
Chulalongkorn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported